Connor, Clark & Lunn Investment Management (CC&L)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-202,525
| Closed | -$2.23M | – | 975 |
|
|
2016
Q1 | $2.23M | Sell |
202,525
-30,375
| -13% | -$334K | 0.02% | 322 |
|
|
2015
Q4 | $2.14M | Buy |
232,900
+25,225
| +12% | +$232K | 0.02% | 328 |
|
|
2015
Q3 | $1.44M | Sell |
207,675
-38,725
| -16% | -$269K | 0.01% | 344 |
|
|
2015
Q2 | $2.42M | Buy |
246,400
+3,300
| +1% | +$32.4K | 0.02% | 215 |
|
|
2015
Q1 | $2.15M | Sell |
243,100
-23,300
| -9% | -$206K | 0.02% | 222 |
|
|
2014
Q4 | $2.33M | Buy |
266,400
+18,700
| +8% | +$164K | 0.02% | 211 |
|
|
2014
Q3 | $1.71M | Buy |
247,700
+63,600
| +35% | +$438K | 0.01% | 230 |
|
|
2014
Q2 | $1.03M | Buy |
184,100
+9,700
| +6% | +$54.3K | 0.01% | 319 |
|
|
2014
Q1 | $876K | Buy |
174,400
+22,700
| +15% | +$114K | 0.01% | 400 |
|
|
2013
Q4 | $812K | Sell |
151,700
-27,200
| -15% | -$146K | 0.01% | 413 |
|
|
2013
Q3 | $932K | Buy |
178,900
+5,700
| +3% | +$29.7K | 0.01% | 275 |
|
|
2013
Q2 | $906K | Buy |
+173,200
| New | +$906K | 0.01% | 274 |
|